University of Texas/MD Anderson Cancer Center SC-3 — Houston, Texas

University of Texas/MD Anderson Cancer Center SC-3 is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Texas/MD Anderson Cancer Center SC-3 has participated in 2 clinical trials.

Therapeutic areas: Dose Escalation, Safety, Preliminary Efficacy.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas/MD Anderson Cancer Center SC-3?

University of Texas/MD Anderson Cancer Center SC-3 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas/MD Anderson Cancer Center SC-3 conducted?

University of Texas/MD Anderson Cancer Center SC-3 has 2 clinical trials on record. Their work covers Dose Escalation, Safety, Preliminary Efficacy.

Is University of Texas/MD Anderson Cancer Center SC-3 accredited by Crixeo Health?

University of Texas/MD Anderson Cancer Center SC-3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas/MD Anderson Cancer Center SC-3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.